<生产厂家价格>

5-甲基胞苷

5-甲基胞苷用途

5-Methylcytidine 为嘧啶核苷,位于多种体液中。

5-甲基胞苷名称

[ CAS 号 ]:
2140-61-6

[ 中文名 ]:
5-甲基胞苷

[ 英文名 ]:
5-Methylcytidine

[英文别名 ]:

Cytidine, 5-methyl-
Cytidine,5-Methyl
5-Methylcytidine
MFCD00006548
5-Methyl-cytidin
EINECS 218-390-8
5-methyl-cytidine

5-甲基胞苷生物活性

[ 描述 ]:

5-Methylcytidine 为嘧啶核苷,位于多种体液中。

[ 相关类别 ]:

天然产物 >> 其他

研究领域 >> 其他

[ 靶点 ]

Human Endogenous Metabolite

[相关活性小分子]

5-甲基胞苷物理化学性质

[ 密度 ]:
1.8±0.1 g/cm3

[ 沸点 ]:
537.5±60.0 °C at 760 mmHg

[ 熔点 ]:
212-215 °C (dec.)(lit.)

[ 分子式 ]:
C₁₀H₁₅N₃O₅

[ 分子量 ]:
257.243

[ 闪点 ]:
278.9±32.9 °C

[ 精确质量 ]:
257.101166

[ PSA ]:
130.83000

[ LogP ]:
-1.35

[ 外观性状 ]:
淡黄色晶体

[ 蒸汽压 ]:
0.0±3.2 mmHg at 25°C

[ 折射率 ]:
1.725

[ 储存条件 ]:
室温，干燥

[ 水溶解性 ]:
水溶性：可溶

5-甲基胞苷MSDS

详细MSDS(安全技术说明书)

5-甲基胞苷安全信息

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
26-36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2934999090

5-甲基胞苷上下游产品

5-甲基胞苷上游产品

5-甲基胞苷下游产品

5-甲基胞苷海关

[ 海关编码 ]: 2934999090

[ 中文概述 ]:
2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

5-甲基胞苷文献

Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.

J. Clin. Invest. 124(7) , 3187-99, (2014)

In atherosclerosis, plaques preferentially develop in arterial regions of disturbed blood flow (d-flow), which alters endothelial gene expression and function. Here, we determined that d-flow regulate...

Modulation of the immune system during postpartum uterine inflammation.

Physiol. Genomics 47(4) , 89-101, (2015)

Postpartum uterine inflammation (endometritis) in the dairy cow is associated with lower fertility at both the time of infection and after the inflammation has resolved. We hypothesized that aberrant ...

DNA methylation and differential gene regulation in photoreceptor cell death.

Cell Death Dis. 5 , e1558, (2014)

Retinitis pigmentosa (RP) defines a group of inherited degenerative retinal diseases causing progressive loss of photoreceptors. To this day, RP is still untreatable and rational treatment development...

更多文献